HIGHLIGHTS
- who: Peir-Haur Hung et al. from the Department of Internal Medicine, Ditmanson Medical Foundation Chia-Yi Christian Hospital, Chiayi, Taiwan Department of Applied Life Science and Health, Chia-Nan University of Pharmacy and Science have published the article: The Histone Demethylase Inhibitor GSK-J4 Is a Therapeutic Target for the Kidney Fibrosis of Diabetic Kidney Disease via DKK1 Modulation, in the Journal: (JOURNAL) of 20/08/2022
- what: In this study mechanism of KDM6A was evaluated in streptozotocin-induced diabetic mice. The study provides novel strategy to eliminate fibrosis in kidneys of DKD mice . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.